Literature DB >> 5322715

Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.

T W Williams, P D Mott, P T Wertlake, J B Rubio, R C Adler, G J Hill, G P Suarez, V Knight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5322715

Source DB:  PubMed          Journal:  Int J Lepr        ISSN： 0020-7349


× No keyword cloud information.
  4 in total

1.  New drug for leprosy.

Authors: 
Journal:  Br Med J       Date:  1969-03-29

2.  Controlled clinical trial of clofazimine in untreated lepromatous leprosy.

Authors:  A B Karat; A Jeevaratnam; S Karat; P S Rao
Journal:  Br Med J       Date:  1971-11-27

3.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Authors:  C E Van Rensburg; G K Jooné; J F O'Sullivan; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  A study of clofazimine in the rat.

Authors:  H L Currey; P D Fowler
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.